Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients
Clinical trial NCT01729663 · UNKNOWN
Trial details
- NCT number
- NCT01729663
- Sponsor
- Laboratorio Pablo Cassara S.R.L.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2018-12-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.